title: Systemic lupus erythematosus in a patient with remitting minimal change nephrotic syndrome.
abstract: Minimal change nephrotic syndrome (MCNS) developed in a 17-year-old female and spontaneously remitted. One month later the nephrotic syndrome relapsed. Prednisolone therapy, 60 mg/day, was started and resulted in a full remission within a week and the prednisolone dose was subsequently tapered. Seven months later, when 10 mg/day of prednisolone was being administered, she developed erythematous rash with photosensitivity and polyarthralgia without exacerbation of the nephrotic syndrome, and fulfilled four of the American College of Rheumatology criteria for classification of systemic lupus erythematosus (SLE). Avoidance of direct sunlight ameliorated the erythematous rash and the polyarthralgia disappeared even though the prednisolone dose was decreased further. This is the first reported case of SLE developed in a patient with remitting MCNS.
authors.affiliation: Kidney Center, Saiseikai Yahata Hospital, Kitakyushu, Japan.
authors.forename: G
authors.initials: G
authors.lastname: Nishihara
authors.forename: M
authors.initials: M
authors.lastname: Nakamoto
authors.forename: C
authors.initials: C
authors.lastname: Yasunaga
authors.forename: K
authors.initials: K
authors.lastname: Takeda
authors.forename: K
authors.initials: K
authors.lastname: Matsuo
authors.forename: M
authors.initials: M
authors.lastname: Urabe
authors.forename: T
authors.initials: T
authors.lastname: Goya
authors.forename: T
authors.initials: T
authors.lastname: Sakemi
mesh_terms: D000293:Adolescent; D001706:Biopsy; D005260:Female; D006801:Humans; D007668:Kidney / Q000473:pathology / Q000648:ultrastructure; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D009402:Nephrosis, Lipoid / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D012008:Recurrence; D012075:Remission, Spontaneous
chemical_list: D011239:Prednisolone